Corpus Intelligence IC Memo — STAR VALLEY HOSPITAL 2026-04-26 13:29 UTC
IC Memo — STAR VALLEY HOSPITAL
Investment Committee Memorandum | WY | 22 beds | Grade C | EBITDA uplift $6.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

STAR VALLEY HOSPITAL

CCN 531313 | LINCOLN, WY | 22 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

STAR VALLEY HOSPITAL is a 22-bed rural/critical access in LINCOLN, WY with $82.0M in net patient revenue and a -0.5% operating margin. The hospital serves a payer mix of 53.0% Medicare, 6.2% Medicaid, and 40.8% commercial.

Thesis: Turnaround. Our ML models identify $6.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.5% to 6.9% (+736bps).

Net Revenue HCRIS$82.0M
Current EBITDA COMPUTED$-385K
Operating Margin COMPUTED-0.5%
Occupancy HCRIS28.7%
Revenue / Bed COMPUTED$3.7M
Net-to-Gross HCRIS66.7%
Distress Probability ML54.8%

2. Market Context & Competitive Position

29
WY Hospitals
-7.5%
State Median Margin
17
Comparable Hospitals

WY has 29 Medicare-certified hospitals with a median operating margin of -7.5%. The target's margin of -0.5% places it above the state median. Among 17 size-comparable peers (11-44 beds), the median margin is -12.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (11-44), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
STAR VALLEY HOSPITAL (Target)WY22$82.0M-0.5%
CODY REGIONAL HEALTHWY25$122.8M-0.9%
MEMORIAL HOSPITAL OF CONVERSE WY25$92.7M-1.9%
POWELL VALLEY HEALTH CAREWY25$69.6M-2.6%
COMMUNITY HOSPITALWY25$35.7M-7.5%
EVANSTON REGIONALWY32$35.3M17.6%
HOT SPRINGS COUNTY MEMORIALWY15$31.6M-15.0%
MEMORIAL HOSPITAL OF CARBON COWY25$30.5M-27.8%
WASHAKIE MEDICAL CENTERWY18$28.1M-1.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.7M+210bp18mo
Cost to Collect4.5%2.5%$1.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$998K+122bp9mo
Clean Claim Rate88.0%96.0%$52K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.7M
Cost to Collect
$1.6M
Denial Rate Reduction
$1.6M
A/R Days Reduction
$998K
Clean Claim Rate
$52K
Total EBITDA Uplift$6.0M
Current EBITDA$-385K
+ RCM Uplift+$6.0M
Pro Forma EBITDA$5.7M
Current Margin-0.5%
Pro Forma Margin6.9%
WC Released (1x)$3.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-592K$57.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-592K$63.4M0.00x-100.0%
Bull Case9.0x11.0x$-533K$83.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-533K$90.5M0.00x-100.0%
Bear Case11.0x10.0x$-651K$27.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-651K$30.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 28.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 11-44 beds
  • Same-state prioritization (n=18)
  • Comp margins: P25=-21.3% / P50=-12.4% / P75=-1.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.